Brain Metastases, Adult · Fase 2 · NCT07132190
Linear accelerator-based stereotactic radiation for brain metastases using 0mm or 1mm PTV
Ayal A. Aizer, MD · Abrir el resumen
Brain Metastases, Adult · Fase 2 · NCT04343157 · Artículos
Cognitive Sparing Brain Stereotactic Radiosurgery (SRS)
Jona Hattangadi-Gluth · Abrir el resumen
Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation · Fase 2 · NCT07286292
Vorasidenib
Institut de Recherches Internationales Servier (I.R.I.S.) · Abrir el resumen
Glioma de alto grado · Fase 2 · NCT06161974
Olutasidenib + TMZ
Rigel Pharmaceuticals · Abrir el resumen
Medulloblastoma · Fase 2 · NCT06701812
Digoxin
H. Lee Moffitt Cancer Center and Research Institute · Abrir el resumen
Basal Ganglia Germinoma · Fase 2 · NCT06368817
3-Dimensional Conformal Proton Radiation Therapy, 3-Dimensional Conformal Radiation Therapy, Biospecimen Collection, Carboplatin
Children's Oncology Group · Abrir el resumen
Glioma de alto grado · Fase 2 · NCT05096481
PEP-CMV, Temozolomide, Tetanus Diphtheria Vaccine
Nationwide Children's Hospital · Abrir el resumen
Glioblastoma · Fase 2 · NCT02977780 · Artículos
Temozolomide, Neratinib, QBS10072S, Abemaciclib
David Reardon, MD · Abrir el resumen
Medulloblastoma · Fase 2 · NCT04696029
Difluoromethylornithine
Giselle Sholler · Abrir el resumen
Brain Cancer Metastatic · Fase 2 · NCT07383649 · Artículos
Valganciclovir
The Methodist Hospital Research Institute · Abrir el resumen
Glioblastoma · Fase 2 · NCT07003542
Sitagliptin
Case Comprehensive Cancer Center · Abrir el resumen
Glioblastoma multiforme · Fase 2 · NCT05708352
Keto Diet, Standard Anti-Cancer Diet
Cedars-Sinai Medical Center · Abrir el resumen
Primary Central Nervous System Lymphoma · Fase 2 · NCT04906096
PAXALISIB
Lakshmi Nayak, MD · Abrir el resumen
Glioblastoma recurrente · Fase 2 · NCT06069726
Atezolizumab
Duke University · Abrir el resumen
Brain Metastases · Fase 2 · NCT05045950
Memantine -Twice Daily or Extended Release, WBRT utilizing the PRDR technique
Medical College of Wisconsin · Abrir el resumen
Cancer Harboring BRAF Alterations · Fase 2 · NCT05503797
Plixorafenib
Fore Biotherapeutics · Abrir el resumen
Glioma · Fase 2 · NCT05188508
Pembrolizumab, Olaparib and Temozolomide
Memorial Sloan Kettering Cancer Center · Abrir el resumen
Glioblastoma, IDH-Wildtype · Fase 2 · NCT05879250
Biospecimen Collection, Magnetic Resonance Imaging, Radiation Therapy, STAT3 Inhibitor WP1066
Northwestern University · Abrir el resumen
Metastatic Malignant Neoplasm to Brain · Fase 2 · NCT02896335
Palbociclib, Pembrolizumab
Massachusetts General Hospital · Abrir el resumen
Recurrent Supratentorial Glioblastoma · Fase 2 · NCT06177964
Lerapolturev, Lomustine Pill
Darell Bigner · Abrir el resumen
Metastatic Solid Tumor · Fase 2 · NCT05673928
Trastuzumab emtansine, Tucatinib
M.D. Anderson Cancer Center · Abrir el resumen
Anaplastic Astrocytoma, IDH-Wildtype · Fase 2 · NCT04623931
Quality-of-Life Assessment, Questionnaire Administration, Radiation Therapy, Temozolomide
M.D. Anderson Cancer Center · Abrir el resumen
Glioblastoma (GBM) · Fase 2 · NCT06805305 · Artículos
DOC1021, Tumor resection, Temodar (Temozolomide), SOC cranial radiation
Diakonos Oncology Corporation · Abrir el resumen
Glioma pontino intrínseco difuso · Fase 2 · NCT05009992 · Artículos
ONC201, Radiation Therapy, Paxalisib, DNX-2401
University of California, San Francisco · Abrir el resumen